-
1
-
-
84862858037
-
Chemical properties of antiepileptic drugs (AEDs)
-
Bialer M,. Chemical properties of antiepileptic drugs (AEDs). Adv Drug Del Rev 2012; 64: 887-895.
-
(2012)
Adv Drug Del Rev
, vol.64
, pp. 887-895
-
-
Bialer, M.1
-
2
-
-
1542752260
-
Examination of the evidence for off-label use of gabapentin
-
Mack A,. Examination of the evidence for off-label use of gabapentin. J Manage Care Pharm 2003; 9: 559-568.
-
(2003)
J Manage Care Pharm
, vol.9
, pp. 559-568
-
-
MacK, A.1
-
3
-
-
40549084978
-
Use of gabapentin in the treatment of behavioural and psychological symptoms of dementia: A review of the evidence
-
Kim Y, Wilkins KM, Tampi RR,. Use of gabapentin in the treatment of behavioural and psychological symptoms of dementia: A review of the evidence. Drugs Aging 2008; 25: 187-196.
-
(2008)
Drugs Aging
, vol.25
, pp. 187-196
-
-
Kim, Y.1
Wilkins, K.M.2
Tampi, R.R.3
-
4
-
-
84869088739
-
The impact of gabapentin administration on brain GABA and glutamate concentrations: A 7T (1)H-MRS study
-
et al.
-
Cai K, Nanga RP, Lamprou L, et al. The impact of gabapentin administration on brain GABA and glutamate concentrations: A 7T (1)H-MRS study. Neuropsychopharmacology 2012; 37: 2764-2771.
-
(2012)
Neuropsychopharmacology
, vol.37
, pp. 2764-2771
-
-
Cai, K.1
Nanga, R.P.2
Lamprou, L.3
-
5
-
-
23844555120
-
Evidence that gabapentin reduces neuropathic pain by inhibiting the spinal release of glutamate
-
et al.
-
Coderre TJ, Kumar N, Lefebvre CD, et al. Evidence that gabapentin reduces neuropathic pain by inhibiting the spinal release of glutamate. J Neurochemy 2005; 94: 1131-1139.
-
(2005)
J Neurochemy
, vol.94
, pp. 1131-1139
-
-
Coderre, T.J.1
Kumar, N.2
Lefebvre, C.D.3
-
6
-
-
0036242083
-
Basic pharmacologic mechanisms involved in benzodiazepine tolerance and withdrawal
-
Bateson AN,. Basic pharmacologic mechanisms involved in benzodiazepine tolerance and withdrawal. Curr Pharm Des 2002; 8: 5-21.
-
(2002)
Curr Pharm des
, vol.8
, pp. 5-21
-
-
Bateson, A.N.1
-
7
-
-
84879413294
-
Craving in alcohol-dependent patients after detoxification is related to glutamatergic dysfunction in the nucleus accumbens and the anterior cingulate cortex
-
et al.
-
Bauer J, Pedersen A, Scherbaum N, et al. Craving in alcohol-dependent patients after detoxification is related to glutamatergic dysfunction in the nucleus accumbens and the anterior cingulate cortex. Neuropsychopharmacology 2013; 38: 1401-1408.
-
(2013)
Neuropsychopharmacology
, vol.38
, pp. 1401-1408
-
-
Bauer, J.1
Pedersen, A.2
Scherbaum, N.3
-
8
-
-
0038079408
-
GABA and its agonists improved visual cortical function in senescent monkeys
-
et al.
-
Leventhal AG, Wang Y, Pu M, et al. GABA and its agonists improved visual cortical function in senescent monkeys. Science 2003; 300: 812-815.
-
(2003)
Science
, vol.300
, pp. 812-815
-
-
Leventhal, A.G.1
Wang, Y.2
Pu, M.3
-
9
-
-
0035014001
-
Glutamate-glutamine cycle and aging in striatum of the awake rat: Effects of a glutamate transporter blocker
-
et al.
-
Segovia G, Del Arco A, Prieto L, et al. Glutamate-glutamine cycle and aging in striatum of the awake rat: Effects of a glutamate transporter blocker. Neurochem Res 2001; 26: 37-41.
-
(2001)
Neurochem Res
, vol.26
, pp. 37-41
-
-
Segovia, G.1
Del Arco, A.2
Prieto, L.3
-
10
-
-
57449093853
-
Withdrawing benzodiazepines in primary care
-
Lader M, Tylee A, Donoghue J,. Withdrawing benzodiazepines in primary care. CNS Drugs 2009; 23: 19-34.
-
(2009)
CNS Drugs
, vol.23
, pp. 19-34
-
-
Lader, M.1
Tylee, A.2
Donoghue, J.3
|